NCT07058129

Brief Summary

This multicenter, prospective registry is to evaluate the efficacy and safety of deep cervical lymphatic venous anastomosis (DC-LVA) in reduing the clinical dementia rating-sum of boxes (CDR-SB) score of Alzheimer's Disease (AD) patients at 12 months after surgery in the real-world.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
814

participants targeted

Target at P75+ for all trials

Timeline
39mo left

Started Jul 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Jul 2025Jul 2029

First Submitted

Initial submission to the registry

May 11, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

July 30, 2025

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2029

Last Updated

July 10, 2025

Status Verified

July 1, 2025

Enrollment Period

3 years

First QC Date

May 11, 2025

Last Update Submit

July 9, 2025

Conditions

Keywords

Alzheimers diseaseCervical lymphatic venous anastomosisRegistry

Outcome Measures

Primary Outcomes (2)

  • The change of Clinical Dementia Rating-Sum of Boxes score at 12th months after surgery

    The change of Clinical Dementia Rating-Sum of Boxes score (CDR-SB, 0-18 score, higher scores mean a worse outcome)

    From baseline to 12th months after surgery

  • The incidence of perioperative complications within 7 days after surgery

    The incidence of perioperative complications

    From baseline to 7th days after surgery

Secondary Outcomes (7)

  • The Change of Clinical Dementia Rating-Sum of Boxes score

    From baseline to 3th, 6th, 18th, 24th months after surgery

  • The Change of Neuropsychiatric Inventory Score

    From baseline to 3th, 6th, 12th,18th, 24th months after surgery

  • The Change of Alzheimer's Disease Assessment Scale-Activity of Daily Living score

    From baseline to 3th, 6th, 12th, 18th, 24th months after surgery

  • The Change of Zarit Caregiver Interview of Alzheimer's Disease Score

    From baseline to 3th, 6th, 12th,18th, 24th months after surgery

  • The Change of Mini-Mental State Examination Score

    From baseline to 3th, 6th, 12th, 18th, 24th months after surgery

  • +2 more secondary outcomes

Interventions

The intervention requires to perform bilateral deep cervical lymphatic venous anastomosis (DC-LVA). Through cervical incision, the deep cervical lymphatic tissue is anatomically dissected and anastomosed with the venous system of the neck. Under indocyanine green (ICG) navigation, the flow of lymphatic fluid into the vein could be observed via ICG tracing fluorescence after surgery.

Also known as: lymphatic venous anastomosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

AD patients who received DC-LVA treatment

You may qualify if:

  • Age ≥ 18 years, male or famale.
  • Diagnosed with AD according to the NIA-AA criteria.
  • Patients who have received DC-LVA treatment;
  • Signed informed consent (by the subject or their relative, and caregiver)

You may not qualify if:

  • Severe neurological deficits in limb movement, language, vision, hearing, or consciousness, or any condition that the investigator determines may prevent the completion of cognitive function assessments.
  • The subject lacks a stable and reliable caregiver to accompany with them during entire study follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hopital, Capital Medical University

Beijing, China

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 11, 2025

First Posted

July 10, 2025

Study Start

July 30, 2025

Primary Completion (Estimated)

July 30, 2028

Study Completion (Estimated)

July 30, 2029

Last Updated

July 10, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations